Anytime, Anywhere.
Drug and device companies have relied on UB Greensfelder to advance their interests for more than 30 years in cases across the country. By partnering with companies to navigate the complex operational, technological and regulatory challenges of today's regulatory, business, and social environments, we are able to mitigate and control emerging threats and overcome potential obstacles at every step in the decision-making process.
UB Greensfelder attorneys defend product liability claims against drug and device manufacturers. We have represented dozens of drug and device companies as national, regional, and local counsel in matters involving hundreds of FDA regulated products from brand (NDA) to generic (ANDA, 505(b)2)) pharmaceutical products covering virtually every class of drug and type of adverse reaction, and class I-III medical devices under 510(k), PMA, IDE, De Novo, approvals, as well as OTC medications and dietary supplements. We are intimately familiar with the regulatory and clinical context in which these cases arise, and are uniquely positioned to have gained key insights on nuanced defenses and novel claims, including public nuisance.
We have been recognized by numerous publications, including Benchmark Litigation (2014-2018) (“Firm of the Year” in Ohio), BTI Consulting Group (2014-2018) (Client Service A-Team), BTI Consulting Group (2013-2017) (Top half of all firms recommended to peers and colleagues), Chambers USA (2003-2017) (Litigation), 2018 U.S. News & World Report (Litigation), The Best Lawyers in America (2018) (56 lawyers) as having one of the premier U.S. practice groups. Whether resolving cases through aggressive discovery, pretrial motions, novel case management, alternative dispute resolution or victories in trial or on appeal, the firm has an established reputation for getting the job done at the optimal value.
National, Regional, and Local Counsel Experience
- Individual or one-off cases
- Complex Litigation
- Mass Torts/Coordinated Proceedings
- National Counsel Engagements
- Class Actions
Depth and Scope of Representations
Representing many drug or device manufacturers as national counsel, we also partner with small and mid-sized companies. Overall, we have represented dozens of pharmaceutical manufacturers, numerous leading medical device manufacturers, and many other related aspects of the industry, including consultants, vendors, component suppliers, distributors and retailers.
Optimal Value Fee Structures
UB Greensfelder offers flexible, predictable and high value fee solutions designed to add value to the attorney-client relationship. The firm devotes significant resources to conducting process improvement initiatives and providing lawyers with the project management skills necessary to handle complex matters, ranging from one-off cases to entire portfolios of matters.
Noteworthy Engagements
- National and coordinating counsel for generic manufacturer in MDL 2804 In re Prescription Opioid Litigation
- National and coordinating counsel for brand manufacturer and distributor defendants in MDL 2545 In re Testosterone Litigation (Defendants’ Steering Cmte.)
- National and coordinating counsel for 505(b)(2) defendant in MDL 2740 Taxotere (Docetaxel) Products Liability Litigation
- National and coordinating counsel for NDA defendant in MDL 2789 Proton-Pump Inhibitor Liability Litigation
- National coordinating and co-lead counsel for generic manufacturer in Yaz/Ocella/Gianvil MDL 2100
- National coordinating and liaison counsel for retailer and manufacturer defendants in MDL 1598 In re Ephedra Products Liability Litigation
- National and coordinating counsel for consolidated litigation involving propoxyphene, MDL 2226 (Lead Counsel and Defendants’ Steering Committees)
- National and coordinating counsel for brand manufacturer in MDL 1736 In re Celexa and Lexapro Products Liability Litigation (Appointed lead counsel in MDL)
- National and coordinating counsel for generic manufacturer in MDL 1507 In re Prempro Products Liability Litigation
- National and coordinating counsel for manufacturer in MDL 2372 In re Watson Fentanyl Patch Products Liability Litigation (Lead Counsel and Defendants’ Steering Committees)
- National and coordinating counsel for defendant in MDL 2419 In re New England Compounding Pharmacy, Inc., Products Liability Litigation
- National and coordinating counsel for a French manufacturer and its US distributor, respectively, in the transvaginal mesh litigation (MDL 2325, and various state courts)
- National and coordinating counsel for an Irish manufacturer and its US distributor, respectively, in the transvaginal mesh litigation (MDL 2326, and various state courts)
- National and coordinating counsel for brand manufacturer in MDL 1736 In re Celexa and Lexapro Products Liability Litigation (Appointed lead counsel in MDL)
- National and coordinating counsel for generic manufacturer in MDL 1507 In re Prempro Products Liability Litigation
- National and coordinating counsel for manufacturer in MDL 2372 In re Watson Fentanyl Patch Products Liability Litigation (Lead Counsel and Defendants’ Steering Committees)
- National and coordinating counsel for defendant in MDL 2419 In re New England Compounding Pharmacy, Inc., Products Liability Litigation
- National and coordinating counsel for a French manufacturer and its US distributor, respectively, in the transvaginal mesh litigation (MDL 2325, and various state courts)
- National and coordinating counsel for an Irish manufacturer and its US distributor, respectively, in the transvaginal mesh litigation (MDL 2326, and various state courts)
